Back to dashboard
CommercialCoverageMedium impact

Urine Drug Testing

Blue Cross & Blue Shield of Mississippi·MS · Pain Management, Psychiatry, Family Medicine +1 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi has updated their medical policy A.2.04.98 for Urine Drug Testing, establishing comprehensive guidelines for both presumptive (immunoassay) and confirmatory (GC/MS, LC/MS) testing in pain management and substance use disorder treatment settings. The policy requires full informed consent before testing and outlines proper interpretation protocols for different testing methods.

Action Required

Action needed
Immediately: Review current urine drug testing protocols to ensure compliance with BCBS Mississippi policy A.2.04.98. Billing team must verify that proper informed consent documentation is obtained before all UDT procedures. Providers should ensure appropriate use of presumptive vs confirmatory testing methods and proper interpretation protocols are followed. Update encounter forms to include consent verification checkboxes for UDT procedures.